Search - tctmd.com

Displaying 121 - 140 of 394

Sort: Relevancy | Date

News Daily News

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

Todd Neale

November 17, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Daily News

mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events

Michael O'Riordan

September 26, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

Caitlin E. Cox

September 09, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

CV Symptoms Deserve More Attention, Quantification: AHA Statement

Yael L. Maxwell

August 18, 2022

News Daily News

‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19

L.A. McKeown

August 10, 2022

News Daily News

Early LV Recovery After TAVI Points to Better 5-Year Survival

Yael L. Maxwell

August 01, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

L.A. McKeown

June 21, 2022

News Daily News

Multidisciplinary Collaboration Tackles CV-Related Long COVID

Todd Neale

June 14, 2022

News Daily News

Heart Failure Risks of Smoking Can Linger for Decades

L.A. McKeown

June 07, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Todd Neale

April 20, 2022

News Daily News

Infertility in Women Linked to Subsequent Risk of HFpEF

L.A. McKeown

April 19, 2022

Advertisement

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

CV Symptoms Deserve More Attention, Quantification: AHA Statement

‘Stunning’ Lack of Data on CV Issues in Pregnant Women With COVID-19

Early LV Recovery After TAVI Points to Better 5-Year Survival

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

Multidisciplinary Collaboration Tackles CV-Related Long COVID

Heart Failure Risks of Smoking Can Linger for Decades

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Underuse of GDMT for Heart Failure Even Worse in Low-Income Countries

Infertility in Women Linked to Subsequent Risk of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content